Cochrane Abstracts
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Acetyl‐L‐carnitine for the Treatment of Diabetic Peripheral Neuropathy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432065/all/Acetyl‐L‐carnitine_for_the_treatment_of_diabetic_peripheral_neuropathy.
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432065/all/Acetyl‐L‐carnitine_for_the_treatment_of_diabetic_peripheral_neuropathy. Accessed April 19, 2025.
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432065/all/Acetyl‐L‐carnitine_for_the_treatment_of_diabetic_peripheral_neuropathy
Acetyl‐L‐carnitine for the Treatment of Diabetic Peripheral Neuropathy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432065/all/Acetyl‐L‐carnitine_for_the_treatment_of_diabetic_peripheral_neuropathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
ID - 432065
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432065/all/Acetyl‐L‐carnitine_for_the_treatment_of_diabetic_peripheral_neuropathy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
